ReviewGels (Basel, Switzerland)2026
Polymeric Nanogels for Skin Applications.
Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Chronic skin inflammatory diseases including psoriasis and atopic dermatitis affect millions worldwide, imposing substantial physical, psychological, and economic burdens. Despite advances in topical therapies, conventional formulations suffer from poor skin penetration, rapid clearance, local and systemic side effects, and suboptimal patient adherence. Polymeric nanogels, internally crosslinked three-dimensional polymer networks with dimensions of 10-200 nm, emerged as promising platforms to overcome these limitations. Their unique properties including high water content, tunable porosity, biocompatibility, deformability, and stimulus-responsive behavior enhance skin penetration allowing for targeted therapeutic action. This review examines nanogel synthesis methods optimized for targeting skin inflammatory diseases, including biopolymer-based approaches utilizing chitosan and hyaluronic acid, offering insights into how different methods and advanced architecture provide multifunctional capacities and bioactivities. Translation challenges including manufacturing scalability, long-term safety assessment, and regulatory compliance are critically discussed alongside emerging opportunities in personalized medicine and smart microneedle integrated systems for adaptive therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.